Adrenoleukodystrophy (ALD) is an X-linked recessive genetic disorder that is caused by the abnormality in the ABCD1 gene present on the X chromosome, leading to the accumulation of very-long-chain fatty acids (VLCFAs) in the brain, nervous system, and adrenal gland.&nbsp;
&nbsp;
Adrenoleukodystrophy Epidemiological Segmentation&nbsp;
The Epidemiological Segmentation of Adrenoleukodystrophy in 7MM from 2017 to 2030 is segmented as:-&nbsp;
<ul>
<li>Total Prevalent Population&nbsp;of Adrenoleukodystrophy</li>
<li>Gender-specific Prevalence of Adrenoleukodystrophy</li>
<li>Gender-specific Diagnosed Prevalent Population of Adrenoleukodystrophy</li>
<li>Type-specific Diagnosed Prevalence in males of Adrenoleukodystrophy</li>
</ul>
&nbsp;
Adrenoleukodystrophy Epidemiology&nbsp;
<ul>
<li>The total prevalent population of Adrenoleukodystrophy in the 7MM in 2017 was 55,242</li>
<li>The prevalent population of Adrenoleukodystrophy in the United States in 2017 was 19,371&nbsp;</li>
<li>Among the EU5, Germany had the highest diagnosed prevalent population of Adrenoleukodystrophy was 1,699&nbsp;</li>
</ul>
&nbsp;
<a style="color: #0066cc;" href="https://www.delveinsight.com/report-store/adrenoleukodystrophy-market" target="_blank" rel="noopener noreferrer">Adrenoleukodystrophy Market</a>
Adrenoleukodystrophy Market Size in the United States in 2017 was USD 523.26 million
&nbsp;
Adrenoleukodystrophy Market Drivers&nbsp;
<ul>
<li>Increased number of potential therapies in the pipeline</li>
<li>Awareness about newborn screening programs</li>
<li>The rise in the number of Childhood Cerebral Adrenoleukodystrophy (CALD) cases</li>
</ul>
&nbsp;
Adrenoleukodystrophy Emerging Drugs
Adrenoleukodystrophy Emerging Drugs are Lenti D, Leriglitazone, MD1003, MGTA-456, OP-101, SOM1201, and many others.&nbsp;&nbsp;
&nbsp;
Adrenoleukodystrophy Key Players
Adrenoleukodystrophy key players are bluebird bio, Minoryx Therapeutics, S.L., MedDay Pharmaceuticals, Magenta Therapeutics, Orpheris Inc, SOM Biotech, and many others.&nbsp;

Adrenoleukodystrophy Market

Adrenoleukodystrophy Symptions, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.